United States Anti-Doping Agency Reauthorization Act

Bill: 113-hr-5614
Sponsor: full_name: Rep. Johnson, Bill [R-OH-6]
Introduced: 2014-09-18
Policy area: Sports and Recreation
Subjects: Athletes

Drug, alcohol, tobacco use

Olympic games
Latest action: action_date: 2014-09-19
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2014-09-18
action_desc: Introduced in House
text: <p>United States Anti-Doping Agency Reauthorization Act - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to: (1) authorize appropriations for the U.S. Anti-Doping Agency for FY2014-FY2020, (2) require that the Agency be recognized worldwide as the independent national anti-doping organization for the United States, and (3) replace the Agency's role in preventing the use by U.S. amateur athletes of performance-enhancing genetic modifications accomplished through gene doping with a role in preventing the use of prohibited performance-enhancing methods adopted by the Agency.</p>

tv_txt: I 113th CONGRESS 2d Session H. R. 5614 IN THE HOUSE OF REPRESENTATIVES September 18, 2014 Mr. Johnson of Ohio (for himself and Mr. Tonko ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To reauthorize the United States Anti-Doping Agency, and for other purposes.

1. Short title This Act may be cited as the United States Anti-Doping Agency Reauthorization Act . 2. Prohibit performance-enhancing methods Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2001 ) is amended— (1) in subsection (a), by striking paragraph (4); and (2) in subsection (b)— (A) in paragraph (1), by inserting and be recognized worldwide as the independent national anti-doping organization for the United States after Committee ; (B) in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (C) in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished through gene-doping and inserting or prohibited performance-enhancing methods adopted by the Agency ; (D) in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency. ; and (E) by striking paragraph (5). 3. Authorization of appropriations Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( 21 U.S.C. 2003 ) is amended to read as follows: 703. Authorization of appropriations There are authorized to be appropriated to the United States Anti-Doping Agency— (1) for fiscal year 2014, $11,300,000; (2) for fiscal year 2015, $11,700,000; (3) for fiscal year 2016, $12,300,000; (4) for fiscal year 2017, $12,900,000; (5) for fiscal year 2018, $13,500,000; (6) for fiscal year 2019, $14,100,000; and (7) for fiscal year 2020, $14,800,000. .